Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

To evaluate the incidence and prevalence of autoimmune encephalitis and compare it to that of infectious encephalitis.

[1]  Jacqueline Palace,et al.  Clinical presentation and prognosis in MOG-antibody disease: a UK study , 2017, Brain : a journal of neurology.

[2]  M. Kamoun,et al.  Improving the antibody-based evaluation of autoimmune encephalitis , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[3]  H. Prüss,et al.  Frequencies of neuronal autoantibodies in healthy controls , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[4]  J. Murray,et al.  Clinical Reasoning: A 54-year-old woman with dementia, myoclonus, and ataxia , 2017, Neurology.

[5]  J. Britton,et al.  Expanded phenotypes and outcomes among 256 LGI1/CASPR2‐IgG–positive patients , 2017, Annals of neurology.

[6]  B. Weinshenker,et al.  Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients , 2017, Annals of neurology.

[7]  V. Lennon,et al.  Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. , 2016, JAMA neurology.

[8]  Gary L. Gallia,et al.  Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[9]  C. Klein,et al.  CSF herpes virus and autoantibody profiles in the evaluation of encephalitis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[10]  P. S. Sillevis Smitt,et al.  The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies , 2016, Neurology.

[11]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[12]  N. Crowcroft,et al.  Encephalitis, Ontario, Canada, 2002–2013 , 2016, Emerging infectious diseases.

[13]  A. Venkatesan,et al.  Encephalitis Hospitalization Rates and Inpatient Mortality in the United States, 2000-2010 , 2014, PloS one.

[14]  Joseph L DeRisi,et al.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.

[15]  A. Venkatesan,et al.  Diagnosis and management of acute encephalitis: A practical approach. , 2014, Neurology. Clinical practice.

[16]  J. Dalmau,et al.  Herpes simplex virus–1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report , 2013, Neurology.

[17]  A. Venkatesan,et al.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  M. Jorge Cardoso,et al.  Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. , 2013, Brain : a journal of neurology.

[19]  N. M. Vora,et al.  Burden of encephalitis-associated hospitalizations in the United States, 1998–2010 , 2013, Neurology.

[20]  L. Honig,et al.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study , 2013, The Lancet Neurology.

[21]  Scott M. Brue,et al.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.

[22]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[23]  J. Dalmau,et al.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  S. Pittock,et al.  Paraneoplastic encephalomyelopathies: pathology and mechanisms , 2011, Acta Neuropathologica.

[25]  J. Schott,et al.  Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis , 2011, Annals of neurology.

[26]  A. Vincent,et al.  Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. , 2010, The Lancet. Infectious diseases.

[27]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[28]  N. Crowcroft,et al.  The epidemiology of acute encephalitis , 2007, Neuropsychological rehabilitation.

[29]  E. Benarroch,et al.  Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. , 2006, Mayo Clinic proceedings.

[30]  Bagher Forghani,et al.  In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  A. Epstein,et al.  Racial disparities in medical care. , 2001, The New England journal of medicine.

[32]  J. Walikonis,et al.  Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. , 1998, Mayo Clinic proceedings.

[33]  W. Hauser,et al.  Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950–1981: I. Epidemiology , 1984, Annals of neurology.